We are currently reinvesting 100% of the profits generated from our products and services into our innovation

Point-of-care in vitro diagnostics specialists with expertise in nanomaterials and lateral flow technology. Experts in ultrasensitive immunoassay development and biointerfaced nanoparticles. Dedicated to connecting people, and advancing training and education in NanoBioTechnology combining leadership with hands-on lab work. Connected with a wide network of innovators and investors, we have applied nanomaterials in both diagnostics and therapy. We reinvest all our revenue into innovation!